Novadaq Technologies (NVDQ) 12.67 $NVDQ
NOVADAQ to Host Analyst & Investor Day on November 17, 2014
GlobeNewswire - Wed Sep 17, 6:00AM CDT
Novadaq Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, will host an Analyst & Investor Day on Monday, November 17, 2014. The event will be held at the Sofitel Hotel in New York, NY from 10:00 a.m. to 2:30 p.m. ET.
NOVADAQ Announces Appointment of Robert S. White to Its Board of Directors
GlobeNewswire - Tue Sep 02, 6:10AM CDT
Novadaq Technologies Inc. ("NOVADAQ" or the "Company" (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, today announced that Robert "Bob" S. White has been appointed to the Company's Board of Directors.
Weakness Seen in Novadaq Technologies (NVDQ) Estimates: Should You Stay Away? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Aug 25, 7:48AM CDT
Novadaq Technologies has seen negative earnings estimate revisions for the current quarter along with a significant decline in its share price for the past month
Nasdaq stocks posting largest volume increases
AP - Thu Aug 14, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
NOVADAQ to Present at the Canaccord Genuity 34th Annual Growth Conference
GlobeNewswire - Wed Aug 06, 4:11PM CDT
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company" (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, announced today that President and CEO, Dr. Arun Menawat, will present the Company's corporate overview at the Canaccord Genuity 34th Annual Growth Conference on Thursday, August 14, 2014 at 1:00 p.m. Eastern Time. The conference will be held at the InterContinental Boston Hotel in Boston, Massachusetts.
Novadaq Technologies swings to USD6.3m profit for Q2 2014
M2 - Wed Aug 06, 7:00AM CDT
Imaging solutions company Novadaq Technologies (NasdaqGM:NVDQ) (TSX:NDQ.TO) disclosed on Tuesday that its net income was USD6.3m for the second quarter of 2014.
NOVADAQ Reports Second Quarter 2014 Financial Results
GlobeNewswire - Tue Aug 05, 6:07AM CDT
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company" (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, today announced financial results for its second quarter ended June 30, 2014. Unless otherwise indicated, all dollar amounts in this press release are expressed in United States ("U.S." dollars.
NOVADAQ to Release Second Quarter Financial Results on August 5, 2014 -- Conference Call to Follow
GlobeNewswire - Tue Jul 22, 6:01AM CDT
Novadaq Technologies Inc. ("NOVADAQ" or "the Company" (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, will announce financial results for the second quarter of 2014 before markets open on Tuesday, August 5, 2014.
Leadership Appointments, Acquisitions, Orphan Drug Designations, Strategic Collaborations, and Technical Updates - Analyst Notes on Aerie, Medical Action, INSYS, Novadaq and Foundation Medicine
PR Newswire - Mon Jun 30, 5:10AM CDT
Today, Analysts Review released its analysts' notes regarding Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), Medical Action Industries Inc. (NASDAQ: MDCI), INSYS Therapeutics, Inc. (NASDAQ: INSY), Novadaq Technologies Inc. (NASDAQ: NVDQ) and Foundation Medicine, Inc. (NASDAQ: FMI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4239-100free.
3 Stocks Spiking on Big Volume
at The Street - Thu Jun 26, 8:20AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
Clinical Trial Initiation, Executive Appointments, Priced Offering, FDA Clearance, and Upcoming Conferences - Analyst Notes on Cytokinetics, Quintiles, Kindred, Volcano, and Novadaq
PR Newswire - Tue Apr 01, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Cytokinetics, Inc. (NASDAQ: CYTK), Quintiles Transnational Holdings, Inc. (NYSE: Q), Kindred Healthcare, Inc. (NYSE: KND), Volcano Corporation (NASDAQ: VOLC), and Novadaq Technologies Inc. (NASDAQ: NVDQ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
NOVADAQ to Present at the 13th Annual Needham Healthcare Conference
Marketwire - Tue Mar 25, 6:02AM CDT
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company" (NASDAQ: NVDQ)(TSX: NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, today announced that David Martin, the company's Vice President of Corporate Development & Investor Relations, will present NOVADAQ's corporate overview at the 13th Annual Needham Healthcare Conference. NOVADAQ is scheduled to present on April 8th at 4:20 pm Eastern Time at The Westin Grand Central Hotel in New York, NY.
Is This the Top for Novadaq (NVDQ)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 17, 6:29AM CDT
Is This the Top for Novadaq (NVDQ)?
Novadaq to Present at March Investor Healthcare Meetings
Marketwire - Mon Mar 03, 6:02AM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company" (NASDAQ: NVDQ)(TSX: NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, today announced that NOVADAQ's management will present the Company's corporate overview at two investor meetings in March.
NOVADAQ to Present at the 2014 RBC Capital Markets Healthcare Conference
Marketwire - Tue Feb 11, 6:01AM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company" (NASDAQ: NVDQ)(TSX: NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, today announced that Dr. Arun Menawat, the company's President and Chief Executive Officer, will present NOVADAQ's corporate overview at the 2014 RBC Capital Markets Healthcare Conference. Novadaq is scheduled to present on February 26that 8:00 am Eastern Time at The New York Palace in New York, NY.
NOVADAQ Reports 2013 Fourth Quarter and Full Year Financial Results
Marketwire - Thu Feb 06, 6:01AM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company" (NASDAQ: NVDQ)(TSX: NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, today announced fourth quarter and full-year 2013 financial results. Unless otherwise indicated, all dollar amounts in this press release are expressed in United States (U.S.) dollars.
NOVADAQ to Host Analyst & Investor Day on November 17, 2014
GlobeNewswire - Wed Sep 17, 6:00AM CDT
Novadaq Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, will host an Analyst & Investor Day on Monday, November 17, 2014. The event will be held at the Sofitel Hotel in New York, NY from 10:00 a.m. to 2:30 p.m. ET. NOVADAQ Announces Appointment of Robert S. White to Its Board of Directors
GlobeNewswire - Tue Sep 02, 6:10AM CDT
Novadaq Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, today announced that Robert "Bob" S. White has been appointed to the Company's Board of Directors. Weakness Seen in Novadaq Technologies (NVDQ) Estimates: Should You Stay Away? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Aug 25, 7:48AM CDT
Novadaq Technologies has seen negative earnings estimate revisions for the current quarter along with a significant decline in its share price for the past month
Nasdaq stocks posting largest volume increases
AP - Thu Aug 14, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
NOVADAQ to Present at the Canaccord Genuity 34th Annual Growth Conference
GlobeNewswire - Wed Aug 06, 4:11PM CDT
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, announced today that President and CEO, Dr. Arun Menawat, will present the Company's corporate overview at the Canaccord Genuity 34th Annual Growth Conference on Thursday, August 14, 2014 at 1:00 p.m. Eastern Time. The conference will be held at the InterContinental Boston Hotel in Boston, Massachusetts. Novadaq Technologies swings to USD6.3m profit for Q2 2014
M2 - Wed Aug 06, 7:00AM CDT
Imaging solutions company Novadaq Technologies (NasdaqGM:NVDQ) (TSX:NDQ.TO) disclosed on Tuesday that its net income was USD6.3m for the second quarter of 2014.
NOVADAQ Reports Second Quarter 2014 Financial Results
GlobeNewswire - Tue Aug 05, 6:07AM CDT
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, today announced financial results for its second quarter ended June 30, 2014. Unless otherwise indicated, all dollar amounts in this press release are expressed in United States ("U.S." dollars. NOVADAQ to Release Second Quarter Financial Results on August 5, 2014 -- Conference Call to Follow
GlobeNewswire - Tue Jul 22, 6:01AM CDT
Novadaq Technologies Inc. ("NOVADAQ" or "the Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, will announce financial results for the second quarter of 2014 before markets open on Tuesday, August 5, 2014. Leadership Appointments, Acquisitions, Orphan Drug Designations, Strategic Collaborations, and Technical Updates - Analyst Notes on Aerie, Medical Action, INSYS, Novadaq and Foundation Medicine
PR Newswire - Mon Jun 30, 5:10AM CDT
Today, Analysts Review released its analysts' notes regarding Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), Medical Action Industries Inc. (NASDAQ: MDCI), INSYS Therapeutics, Inc. (NASDAQ: INSY), Novadaq Technologies Inc. (NASDAQ: NVDQ) and Foundation Medicine, Inc. (NASDAQ: FMI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4239-100free.
3 Stocks Spiking on Big Volume
at The Street - Thu Jun 26, 8:20AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
Clinical Trial Initiation, Executive Appointments, Priced Offering, FDA Clearance, and Upcoming Conferences - Analyst Notes on Cytokinetics, Quintiles, Kindred, Volcano, and Novadaq
PR Newswire - Tue Apr 01, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Cytokinetics, Inc. (NASDAQ: CYTK), Quintiles Transnational Holdings, Inc. (NYSE: Q), Kindred Healthcare, Inc. (NYSE: KND), Volcano Corporation (NASDAQ: VOLC), and Novadaq Technologies Inc. (NASDAQ: NVDQ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
NOVADAQ to Present at the 13th Annual Needham Healthcare Conference
Marketwire - Tue Mar 25, 6:02AM CDT
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"
(NASDAQ: NVDQ)(TSX: NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, today announced that David Martin, the company's Vice President of Corporate Development & Investor Relations, will present NOVADAQ's corporate overview at the 13th Annual Needham Healthcare Conference. NOVADAQ is scheduled to present on April 8th at 4:20 pm Eastern Time at The Westin Grand Central Hotel in New York, NY. Is This the Top for Novadaq (NVDQ)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 17, 6:29AM CDT
Is This the Top for Novadaq (NVDQ)?
Novadaq to Present at March Investor Healthcare Meetings
Marketwire - Mon Mar 03, 6:02AM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"
(NASDAQ: NVDQ)(TSX: NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, today announced that NOVADAQ's management will present the Company's corporate overview at two investor meetings in March. NOVADAQ to Present at the 2014 RBC Capital Markets Healthcare Conference
Marketwire - Tue Feb 11, 6:01AM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"
(NASDAQ: NVDQ)(TSX: NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, today announced that Dr. Arun Menawat, the company's President and Chief Executive Officer, will present NOVADAQ's corporate overview at the 2014 RBC Capital Markets Healthcare Conference. Novadaq is scheduled to present on February 26that 8:00 am Eastern Time at The New York Palace in New York, NY. NOVADAQ Reports 2013 Fourth Quarter and Full Year Financial Results
Marketwire - Thu Feb 06, 6:01AM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"
(NASDAQ: NVDQ)(TSX: NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, today announced fourth quarter and full-year 2013 financial results. Unless otherwise indicated, all dollar amounts in this press release are expressed in United States (U.S.) dollars. 
